Health Catalyst (HCAT) Misses Q1 EPS by 56c

Health Catalyst (NASDAQ: HCAT) reported Q1 EPS of ($0.60), $0.56 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $73.87 million versus the consensus estimate of $71.23 million.

For earnings history and earnings-related data on Health Catalyst (HCAT) click here.

You May Also Be Interested In

• Monolithic Power Systems (MPWR) Reiterated at Buy by Stifel on Reaching $4B Target
• Morgan Stanley cautious on Coinbase, but target implies over 40% upside
• Labcorp sets long-term growth targets at investor day